Menu
Montecito
Pac Premier
Giving Guide
Loading...
You are here:  Home  >  Banking & Finance  -  Page 58

Montecito Bank & Trust
Latest

Our view: How Cal Poly SLO can achieve diversity

By   /  Friday, October 25th, 2019  /  Banking & Finance, Central Coast, Editorials, Education, Latest news, Opinion  /  Comments Off on Our view: How Cal Poly SLO can achieve diversity

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Two Central Coast technology companies raise $150 million

By   /  Friday, October 25th, 2019  /  Biotech, East Ventura County, right, South Coast, Startups, Technology, Top Stories, Tri-County Public Companies  /  Comments Off on Two Central Coast technology companies raise $150 million

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Deckers earnings beat analyst expectations

By   /  Thursday, October 24th, 2019  /  Earnings, Latest news, South Coast, Tri-County Public Companies  /  Comments Off on Deckers earnings beat analyst expectations

Goleta-based footwear and apparel company Deckers Brands reported an 8 percent increase in its second quarter revenue Oct. 24, beating analyst expectations with $2.71 in earnings per share. The company also announced the appointment of a new chairman to its board of directors, board member and former CFO of Coach Inc., Mike Devine. Former chairman Read More →

Read More →
Latest

Amgen cuts list price of Repatha by 60 percent

By   /  Thursday, October 24th, 2019  /  Biotech, East Ventura County, Latest news, Tri-County Public Companies  /  Comments Off on Amgen cuts list price of Repatha by 60 percent

Amgen doubled down on its decision to slash the list price of one of its newest drugs, Repatha, listing it for all patients at $5,840 per year. The Thousand Oaks-based biotech giant reduced the list price by 60 percent for some patients for the cholesterol medication a year before, and the announcement Oct. 24 discontinues Read More →

Read More →
Latest

Amgen warns investors of ‘mini-tender’ offer

By   /  Wednesday, October 23rd, 2019  /  Biotech, Latest news, Tri-County Public Companies  /  Comments Off on Amgen warns investors of ‘mini-tender’ offer

Biotech giant Amgen warned investors of a so-called “mini-tender” offer by TRC Capital Corp. that seeks to buy half a million of the company’s shares at below-market prices ahead of its third quarter earnings. The unsolicited offer is dated Oct. 11 and offers to purchase up to 500,000 of Amgen common stock at $192 per Read More →

Read More →
Latest

Dubroff: Zuckerberg plays monopoly, dodges the truth

By   /  Wednesday, October 23rd, 2019  /  Biotech, East Ventura County, Latest news, Tri-County Public Companies  /  Comments Off on Dubroff: Zuckerberg plays monopoly, dodges the truth

Henry Dubroff

After watching Facebook chief executive Mark Zuckerberg labor to explain his company’s policies on privacy, diversity and currency in testimony before Congress on Oct. 23, I have come to some conclusions about the social media giant and its future. Like any company with monopoly or near-monopoly power, Facebook is way too concerned about costs. It Read More →

Read More →
Latest

Teledyne shares soar as earnings beat estimates

By   /  Wednesday, October 23rd, 2019  /  Earnings, East Ventura County, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Teledyne shares soar as earnings beat estimates

Shares of Thousand Oaks-based Teledyne Technologies jumped nearly 6 percent or $18 on Oct. 23 after the company reported quarterly results that beat estimates. Teledyne shares were trading in the $330 range in afternoon trading after the company reported adjusted earnings of $2.57 per share and revenue of $802.20 million for the quarter ended September Read More →

Read More →